[A Case of Unresectable Pancreatic Cancer with Massive Cancerous Ascites Responsive to KM-CART]

Gan To Kagaku Ryoho. 2021 Jan;48(1):81-83.
[Article in Japanese]

Abstract

A 79-year-old woman visited our hospital complaining of bloating. An abdominal enhanced CT scan revealed pancreatic body cancer with cancerous ascites and multiple liver metastases. We started gemcitabine(GEM)plus nab-paclitaxel chemotherapy. Chemotherapy was not continued because she was unable to take oral medication owing to increased cancerous ascites. We conducted modified KM-cell-free and concentrated ascites reinfusion therapy(KM-CART). Her symptoms improved, and she began having oral intake after KM-CART. Chemotherapy was then re-initiated. Seven months have now passed since we started chemotherapy, and we can continue chemotherapy while conducting KM-CART repeatedly. KM- CART is useful for treating unresectable pancreatic cancer with massive cancerous ascites in terms of continuing chemotherapy.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Ascites / etiology
  • Female
  • Humans
  • Paclitaxel / therapeutic use
  • Pancreatic Neoplasms* / complications
  • Pancreatic Neoplasms* / drug therapy
  • Peritoneal Neoplasms* / drug therapy

Substances

  • Paclitaxel